Delivery Order SPE2DB20D7066-SPE2DB25FC4SA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Cryselle-28 tablets, a birth control medication, with a ceiling value of $5,708.05. This is a firm fixed-price delivery order with an ultimate completion date of September 15, 2025, and represents a non-set-aside competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,089.41 Firm Fixed Price Delivery Order is for the supply of CRYSELLE-28 TABLET 28S, a pharmaceutical product. The contract has a period of performance through May 6, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,702.12, is for the delivery of CRYSELLE-28 TABLET 28S medical supplies. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price contract type. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,153.66, is for the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a performance period through March 31, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $308.16 to Amerisourcebergen Drug Corporation. The order is for 4561563150 CRYSELLE-28 TABLET 28S to be delivered to a location in Conshohocken, Pennsylvania by July 24, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform under the contract from its Conshohocken facility. The Defense Logistics Agency utilizes such contracts and delivery orders to...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CRYSELLE-28 TABLET 28S, a pharmaceutical product, with a ceiling value of $1,867.56 and a performance period ending on June 17, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $2,744.56 to AmerisourceBergen Drug Corp for Drospirenone-EE 3-0.02 mg tablets (28-count), a hormonal contraceptive medication. The award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location....
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a competitive delivery order valued at $2,324.60 from the Defense Logistics Agency's Medical Supply Chain on September 4, 2025. Designated as a firm fixed-price contract with no set-aside provisions, this delivery order is structured as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order against its indefinite delivery contract with the Defense Logistics Agency (DLA) Troop Support Medical. Valued at $3,875.16, this order is for the supply of 4562794254 low-dose oral contraceptive tablets to be delivered to DLA's Conshohocken, Pennsylvania facility by November 14, 2023. As the prime contractor, Amerisourcebergen will provide the specified pharmaceutical products in support of DLA's provision of medical...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Drospirenone 4mg tablets in a 28-count package. This competitive, non-set-aside award carries a firm fixed price ceiling value of $7,458.51 and is scheduled for completion by September 24, 2025. The order will be fulfilled from AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and...
- SPE2DB20D7066Indefinite Delivery Contract
- SPE2DB20D7066-SPE2DB25FC4SADelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,741.91 to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Cryselle-28 tablets. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $1 billion and extending through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare systems. This delivery order for Cryselle-28, an oral contraceptive medication, exemplifies the company's role in fulfilling routine pharmaceutical needs across the Defense Health Agency and related government healthcare systems. The award involved no set-aside designation, reflecting AmerisourceBergen's competitive capability to meet federal procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 9/10/25 |